Monday, September 11, 2006

Why I bought Advanced Nutraceuticals

I've gotten a bit behind in my investment rationals, so before I forget, I better write this down. This is another going-private transaction that was initially priced at $3.20 a share for holders of fewer than 500 shares. On July 25, the offer was raised to $4 a share. Up to now, my rule has been to wait for a definative proxy before buying into these sorts of special situations, but I realized that raising the price of the offering is a similar signal that the transaction will happen. There's no particular reason a company should raise the offer unless the SEC thinks it is unfairly low, so once the offer is raised, there's a good chance the going-private transaction will be approved.

No comments: